Results 91 to 100 of about 268,751 (268)

The impact of cyclin D1 mRNA isoforms, morphology and p53 in mantle cell lymphoma: p53 alterations and blastoid morphology are strong predictors of a high proliferation index

Haematologica, 2012
Background Mantle cell lymphoma is a clinically heterogeneous disease characterized by overexpression of cyclin D1 protein. Blastoid morphology, high proliferation, and secondary genetic aberrations are markers of aggressive behavior.
Julia Slotta-Huspenina, Ina Koch, Laurence de Leval, Gisela Keller, Margit Klier, Karin Bink, Marcus Kremer, Mark Raffeld, Falko Fend, Leticia Quintanilla-Martinez   +9 more
doaj   +1 more source

Synthesis and Application of Bioactive N‐Functionalized Aziridines

Angewandte Chemie, Volume 137, Issue 44, October 27, 2025.
This review discusses modern synthetic methods for the preparation of aziridine‐containing small molecules, including biocatalytic, electrocatalytic, and photocatalytic strategies. We highlight the compatibility of various synthetic methods with control of the exocyclic N‐substituent.
Hao Tan, Samya Samanta, Nan Qiu, Alexander Adibekian, David C. Powers   +4 more
wiley   +1 more source

Cutaneous lesions as presentation form of mantle cell lymphoma

Dermatology Reports, 2011
Mantle cell lymphoma is a type of no-Hodgkin lymphoma that affects extranodal areas, especially, bone narrow, digestive tract and Waldeyer ring. Here we report a case of mantle cell lymphoma IV Ann Arbor stage with cutaneous lesions on nasal dorsum and ...
Nayra Merino de Paz, Marina Rodriguez-Martin, Patricia Contreras Ferrer, Sonia Garcia-Hernandez, Nieves Hernandez de Leon, Antonio Martin-Herrera, Antonio Noda-Cabrera   +6 more
doaj   +1 more source

Significance of Bcl-2 and Bcl-6 immunostaining in B-Non Hodgkin's lymphoma

Hematology Reports, 2011
The determination of prognosis for B-Non- Hodgkin’s lymphoma (NHL) is known to be related to the multiple differences in tumor cell biology. Bcl-2 and Bcl-6 are two markers linked to germinal center B cells.
Hanan Mohamed Mahmoud, Yasmin Nabil Elsakhawy   +1 more
doaj   +1 more source

Immunohistochemical Analysis of Cyclin D1 Protein in Hematopoietic Neoplasms with Special Reference to Mantle Cell Lymphoma [PDF]

, 1994
Shigeo Nakamura, Masao Seto, Shogo Banno, Susumu Suzuki, Takashi Koshikawa, Kuniyoshi Kitoh, Yoshitoyo Kagami, Michinori Ogura, Yasushi Yatabe, M. Kojima, Tadashi Motoori, Toshitada Takahashi, Ryuzo Ueda, Taizan Suchi   +13 more
openalex   +1 more source

A rare case of breast carcinoma co-existing with axillary mantle cell lymphoma

World Journal of Surgical Oncology, 2003
Background Mantle cell lymphoma (MCL) is a rare variety of non-Hodgkin's lymphoma which originates from CD5+ B-cell population in the mantle zones of lymphoid follicles. Coexistence of such tumours in the axillary lymph nodes with invasive breast cancers
Scally John, Stafford Joanna A, Dutta Roy Subhajit, Selvachandran S N   +3 more
doaj   +1 more source

Autoreactive T-cell-dependent polyclonal B-cell differentiation in mantle zone lymphoma [letter] [PDF]

, 1993
M Hirokawa, M Lee, A Chubachi, A Kitabayashi, T Itoh, I Miura, AB Miura   +6 more
openalex   +1 more source

A phase 2 study of rituximab, bendamustine, bortezomib and dexamethasone for first-line treatment of older patients with mantle cell lymphoma

Haematologica, 2018
We present results of a prospective, multicenter, phase II study evaluating rituximab, bendamustine, bortezomib and dexamethasone as first-line treatment for patients with mantle cell lymphoma aged 65 years or older. A total of 74 patients were enrolled (
R. Gressin, N. Daguindau, A. Tempescul, A. Moreau, S. Carras, E. Tchernonog, A. Schmitt, R. Houot, C. Dartigeas, J. Pignon, S. Corm, A. Banos, C. Mounier, J. Dupuis, M. Macro, J. Fleury, F. Jardin, C. Sarkozy, G. Damaj, P. Feugier, L. Fornecker, C. Chabrot, V. Dorvaux, K. Bouadallah, S. Amorin, R. Garidi, L. Voillat, B. Joly, P. S. Celigny, N. Morineau, M. Moles, H. Zerazhi, J. Fontan, Y. Arkam, M. Alexis, V. Delwail, J. Vilque, L. Ysebaert, S. le Gouill, M. Callanan   +39 more
semanticscholar   +1 more source

Adhesion molecule profiles of B-cell non-Hodgkin's lymphomas in the leukemic phase

Brazilian Journal of Medical and Biological Research, 2006
We evaluated the expression of 10 adhesion molecules on peripheral blood tumor cells of 17 patients with chronic lymphocytic leukemia, 17 with mantle-cell lymphoma, and 13 with nodal or splenic marginal B-cell lymphoma, all in the leukemic phase and ...
D.M. Matos, E.G. Rizzatti, A.B. Garcia, D.A.P. Gallo, R.P. Falcão   +4 more
doaj  

Synergy of NVP-BEZ235 and enzastaurin in mantle cell lymphoma

Clinical Management Issues, 2014
Mantle cell lymphoma (MCL) is a neoplasm classified as a B-cell malignancy, that accounts for approximately 3 to 8% of Non-Hodgkin’s lymphoma (NHL) cases diagnosed annually. MCL is difficult to treat and seldom considered cured.
Monica Civallero, Maria Cosenza
doaj   +1 more source